Diagnostic accuracy of multitarget stool DNA testing for colorectal cancer screening: A systematic review and meta-analysis

Sung, 2021, Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Vabi, 2021, Implications of the growing incidence of global colorectal cancer, J Gastrointest Oncol, 12, S387, 10.21037/jgo-2019-gi-06 Cao, 2021, Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020, Chin Med J (Engl), 134, 783, 10.1097/CM9.0000000000001474 Arnold, 2017, Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66, 683, 10.1136/gutjnl-2015-310912 Bray, 2017, Colorectal cancer screening, WMJ, 116, 27 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colorectal cancer Screening, Version 2. 2020 – June 8, 2020. Dolatkhah, 2020, Development and validation of Persian risk assessment tool using national comprehensive cancer network guideline for colorectal cancer screening, J Clin Diagn Res, 14, LC01 Benard, 2018, Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations, World J Gastroenterol, 24, 124, 10.3748/wjg.v24.i1.124 Li, 2019, Systematic review of the methodology quality and reporting quality in colorectal cancer screening guidelines, Zhonghua Yu Fang Yi Xue Za Zhi, 53, 398 Kisiel, 2020, Multitarget stool DNA for average risk colorectal cancer screening: major achievements and future directions, Gastrointest Endosc Clin N Am, 30, 553, 10.1016/j.giec.2020.02.008 Lidgard, 2013, Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia, Clin Gastroenterol Hepatol, 11, 1313, 10.1016/j.cgh.2013.04.023 Naber, 2019, Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries, PLOS ONE, 14, e0220234, 10.1371/journal.pone.0220234 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Harbord, 2009, metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression, Stata J, 9, 211, 10.1177/1536867X0900900203 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Dwamena BA, Sylvester A, Carlos RC. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Deeks, 2005, The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed, J Clin Epidemiol, 58, 882, 10.1016/j.jclinepi.2005.01.016 Redwood, 2016, Stool DNA testing for screening detection of colorectal neoplasia in alaska native people, Mayo Clin Proc, 91, 61, 10.1016/j.mayocp.2015.10.008 Imperiale, 2004, Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population, N Engl J Med, 351, 2704, 10.1056/NEJMoa033403 Mu, 2020, Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia, Clin Chim Acta, 501, 42, 10.1016/j.cca.2019.12.001 Park, 2017, Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population?, Intest Res, 15, 495, 10.5217/ir.2017.15.4.495 Bosch, 2019, Multitarget stool DNA test performance in an average-risk colorectal cancer screening population, Am J Gastroenterol, 114, 1909, 10.14309/ajg.0000000000000445 Sun, 2019, A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population, J Cancer Res Clin Oncol, 145, 2423, 10.1007/s00432-019-02992-2 Tagore, 2003, Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia, Clin Colorectal Cancer, 3, 47, 10.3816/CCC.2003.n.011 Wilkins, 2018, Colorectal cancer screening and prevention, Am Fam Physician, 97, 658 Wilkins, 2008, Colorectal cancer: a summary of the evidence for screening and prevention, Am Fam Physician, 78, 1385 Lee, 2014, Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis, Ann Intern Med, 160, 171, 10.7326/M13-1484 Zheng, 2003, Cluster randomization trial of sequence mass screening for colorectal cancer, Dis Colon Rectum, 46, 51, 10.1007/s10350-004-6496-2 Ahlquist, 2000, Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel, Gastroenterology, 119, 1219, 10.1053/gast.2000.19580 Imperiale, 2014, Multitarget stool DNA testing for colorectal-cancer screening, N Engl J Med, 370, 1287, 10.1056/NEJMoa1311194 Ahlquist, 2012, Next-generation stool DNA test accurately detects colorectal cancer and large adenomas, Gastroenterology, 142, 248, 10.1053/j.gastro.2011.10.031 Ladabaum, 2016, Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia, Gastroenterology, 151, 427, 10.1053/j.gastro.2016.06.003 Obuch, 2015, Sessile serrated polyps: detection, eradication, and prevention of the evil twin, Curr Treat Options Gastroenterol, 13, 156, 10.1007/s11938-015-0046-y Ahlquist, 2019, Stool-based tests vs screening colonoscopy for the detection of colorectal cancer, Gastroenterol Hepatol (N Y), 15, 437